baber/WOPTO huggingface dataset:
Patent MX-PA03001396-A (MX)
Title: Universal paint solvent.
Inventor: SAQUET XENOPHON G
IPC: C09D7/00
Filed: 2001-08-14
Abstract: A universal paint solvent comprises, on a weight bais, 1-30% of an acidic material selected from the group consisting of sulfonic acids, phosphonic acids, phosphoric acids, and combinations thereof; together with 10-80% of an organic solvent selected from the group consisting of alcohols, ethers, ketones, aldehydes, esters, and combinations thereof. In particular compositions, the acidic component is comprised of a mixture of two different acids. Alkyl esters, particularly acetate esters, are preferred organic solvents. Butyl acetate is a specifically preferred solvent. The compositions solvate a large variety of different paint formulations, and are effective at room temperature. The compositions have particular utility for cleaning paint delivery systems and equipment.
Patent MX-PA03008983-A (MX)
Title: Production of patterned coated abrasive surfaces.
Inventor: SWEI GWO SHIN
IPC: B24D3/00
Filed: 2002-03-28
Abstract: An electrostatic abrasive grain deposition process can be adapted to produce a patterned abrasive surface by controlling the local intensity of the field by which the grain (5) is projected on to a substrate (3).
Patent MX-PA04004994-A (MX)
Title: Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy.
Inventor: BURZYNSKI STANISLAW R
IPC: A61P39/02
Filed: 2002-11-21
Abstract: Pharmaceutical compositions effective in alleviating or reducing the effects of fatigue and weakness associated with cancer and cytotoxic cancer chemotherapy are disclosed. The pharmaceutical compositions of the present invention comprise riboflavin, effectors of the urea cycle in free form or pharmacologically acceptable salts thereof, and amino acids selected from the gorups of essential and non-essential amino acids, in free form or pharmaceutically acceptable salts thereof, suitably combined with appropriate carriers, diluents, or excipients. Also disclosed are methods of alleviating or reducing the effects of fatigue and weakness associated with cancer and cytotoxic cancer chemotherapy by administration of pharmaceutical compositions of the present invention.
Patent MX-PA04005850-A (MX)
Title: Natural fibers treated with acidic odor control/binder systems.
Inventor: RONALD L EDENS
IPC: A61L15/46
Filed: 2002-09-20
Abstract: A fibrous material, which can be an absorbent material, includes a plurality of natural fibers treated with a carboxylic acid-based odor control agent, which are able to withstand insults with an aqueous liquid without dissolving the odor control agent. The acid-based odor control agent is bound to the natural fibers by an organosilicone polymer binder. The binder is water-insoluble, and can form a highly gas permeable coating. The binder is also highly porous, so as to expose the odor control agent to ammonia and other odoriferous gases whichit is intended to control.
Patent MX-PA04008955-A (MX)
Title: Amplification-hybridisation method for detecting and typing human papillomavirus.
Inventor: TIBOR TAKACS
IPC: C12Q1/70
Filed: 2003-03-10
Abstract: The present invention provides amplification and hybridisation method for detecting and typing human papillomavirus (HPV), and the primers and hybridisation probes used in the method. The invention relates to a concrete part of the HPV genome, which is suitable for designing HPV genus-specific and HPV genotype-specific hybridisation oligonucleotide probes.
Patent MX-PA04011606-A (MX)
Title: Electronic device for optimising energy of a solar panel.
Inventor: PEREZ JAIME VEGA
IPC: F24J2/00
Filed: 2004-11-23
Abstract: Described herein is an electronic device for optimising the electric energy provided by a solar panel. The device performance is based on an electric scanning of the voltage and current curves of the solar panel, the voltage and current samples being captured by electronic circuits, thus determining the maximum value of the electric power in the solar module, transforming the captured power, and increasing voltage so that the solar panel current may flow to an automotive battery. The device was designed in such a manner so that the plurality of circuits are suitably coupled and connected, thereby accurately calculating the magnitude of the electronic components useful for processing and capturing the electric signals of the solar panel, therefore the maximum power of this latter element is captured and transformed for using the energy thereof, regardless of an increase in the temperature of the panel or a reduction in the sunlight level. The inventive electric device comprises two ele ctronic sections, the first section detecting the maximum power and storing the solar panel energy, the second section transforming the stored energy and increasing voltage for transferring current into an automotive battery. The device will be useful for solar systems having low power of from about 30 Watts to about 50 Watts, the device being easily used in rural zones.
Patent MX-PA05002074-A (MX)
Title: Pharmaceuticals formulations and methods for modified release of statin drugs.
Inventor: DEVANE JOHN
IPC: A61K31/225
Filed: 2003-09-03
Abstract: The present invention is directed to compositions and methods of their use in treating, preventing, and/or managing one or more cardiovascular diseases using at least one poorly water-soluble statin, such as, for example, simvastatin and/or lovastatin. One method of the invention involves delaying release of the poorly water-soluble statin for a time sufficient to avoid metabolism of the statin at or near the gastrointestinal tract wall by the cytochrome P450 3A metabolic system, and releasing said statin in the ileum, colon, or both, with subsequent uptake into the hepatic portal vein and distribution to hepatocytes, wherein HMG-CoA reductase activity may be inhibited with minimal adverse drug interactions.
Patent MX-PA05002546-A (MX)
Title: Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist.
Inventor: HURTH KONSTANZE
IPC: A61P25/22
Filed: 2003-09-03
Abstract: The present invention relates to 1-aza-bicycloalkyl derivatives of formula (I), wherein X is CH2 or a single bond; Y is a group of formula (II, III, IV) and wherein R has the meanings as defined in the specification, which compounds are alpha 7 nicotinic acetylcholine receptor (nAChR) agonists; to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
Patent MX-PA05005385-A (MX)
Title: Composition and method for treating lupus nephritis.
Inventor: NEGIN SHOJAEE
IPC: C07K14/47
Filed: 2003-11-21
Abstract: The present invention provides novel isolated BFLP0169 polynucleotides and polypeptides encoded by the BFLP0169 polynucleotides. Also provided are the antibodies that immunospecifically bind to a BFLP0 169 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the BFLP0169 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the BFLP0169 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
Patent MX-PA05006161-A (MX)
Title: Method of managing auxiliary programs and a corresponding receiver and system.
Inventor: MARY-LUC CHAMPEL
IPC: H04N5/00
Filed: 2005-06-09
Abstract: This method of managing auxiliary programs broadcast with main programs in a digital data stream comprises: a step of receiving a plurality of digital data streams including said digital data stream; a step of detecting data identifying all the auxiliary programs contained in said digital data stream; a step of extracting all the identified auxiliary programs in the stream; and a step of the receiver storing all of the auxiliary programs identified and extracted from the stream. It advantageously includes a step of access to an auxiliary program which includes a substep of fast transmission of all or a portion of the stored auxiliary program.
Patent MX-PA05007249-A (MX)
Title: Transition between a rectangular waveguide and a microstrip line.
Inventor: ALI LOUZIR
IPC: H01P5/107
Filed: 2003-12-22
Abstract: The invention relates to a transition between a rectangular waveguide and a microstrip line. According to the invention, a ribbed rectangular waveguide is produced in a bar of synthetic material having a metallised base under the rib which extends in the form of a plate of synthetic material, thereby forming a substrate for the microstrip line. Moreover, the base of the rib extends between the upper plane of the ribbed waveguide and the upper plane of the substrate, the microstrip line being disposed on the upper plane of the substrate in the rib base extension.
Patent MX-PA05008926-A (MX)
Title: 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof.
Inventor: PHILLIPS TERESA YOUNGPETER
IPC: C07D453/02
Filed: 2004-02-20
Abstract: The present invention relates to 3-substituted-2-(arylalkyl)-1-azabicycloalkanes, methods of preparing the compounds and methods of treatment using the compounds. The azabicycloalkanes generally are azabicycloheptanes, azabicyclooctanes, or azabicyclononanes. The aryl group in the arylalkyl moiety is a 5- or 6-membered ring heteroaromatic, preferably 3-pyridinyl and 5-pyrimidinyl moieties, and the alkyl group is typically a C1-4 alkyl. The substituent at the 3-position of the 1-azabicycloalkane is a carbonyl group-containing moiety, such as an amide, carbamate, urea, thioamide, thiocarbamate, thiourea or similar functionality. The compounds exhibit activity at nicotinic acetylcholine receptors (nAChRs), particularly the a7 nAChR subtype, and are useful towards modulating neurotransmission and the release of ligands involved in neurotransmission. Methods for preventing or treating conditions and disorders, including central nervous system (CNS) disorders, which are characterized by an alteration in normal neurotransmission, are also disclosed. Also disclosed are methods for treating inflammation, autoimmune disorders, pain and excess neovascularization, such as that associated with tumor growth.
Patent MX-PA05011447-A (MX)
Title: Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives.
Inventor: MATTHEW P WHITESIDE
IPC: C05G3/60
Filed: 2004-04-28
Abstract: Certain novel (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxane derivatives have provided unexpected insecticidal activity. These compounds are represented by formula I: where R through R10, inclusively, x, A, B, y, D, E, G and M are fully described herein. Preferred compounds of the present invention are those wherein the benzofused ring moiety is attached to the remainder of the molecule at the positions designated as 1-or 2-. In addition, compositions comprising an insecticidally effective amount of at least one compound of formula I, and optionally, an effective amount of at least one of a second compound, with at least one insecticidally compatible carrier are also disclosed; along with methods of controlling insects comprising applying said compositions to a locus where insects are present or are expected to be present.
Patent MX-PA05012530-A (MX)
Title: Machine for preparing hot beverages by extracting a substance packaged inside a capsule.
Inventor: SCHIFFERLE RENE
IPC: A47J31/40
Filed: 2005-11-21
Abstract: The beverage machine for preparing a hot beverage by brewing and extracting a substance received in a cartridge is provided with a brewing chamber comprising a lower brewing chamber portion and a closure element. The lower portion of the brewing chamber serves for positively receiving of the cartridge. On both the lower brewing chamber portion and the closure element, piercing elements are provided for piercing the cartridge at opposite sides thereof. Upon closing the brewing chamber, the lower portion thereof, together with the cartridge received therein, is axially moved relative to the closure member to such an extent that the cover of the cartridge is pierced by means of the one piercing member. The bottom of the cartridge is pierced by the other piercing member only to such an extent that the tip of the piercing member penetrates the bottom of the cartridge, without a beverage outlet channel provided in the other piercing element being connected to the interior of the cartridge.
Patent MX-PA05012636-A (MX)
Title: Migraine remedy.
Inventor: STENSWICK LARRY ELLSWORTH
IPC: A61K31/353
Filed: 2004-05-21
Abstract: The invention relates to uses and methods of treating migraine with a plant extract that includes a therapeutically effective dose of a mixture of flavonoids rich in proanthocyanidis. Methods and uses are described to substantially prevent migraine from occurring; reduce the frequency of migraine or reduce the severity of migraine symptoms.
Patent MX-PA05014018-A (MX)
Title: Device for multi-stage heat exchange and method for producing one such device.
Inventor: MAUCHER ULRICH
IPC: F02B29/04
Filed: 2004-06-09
Abstract: The invention relates to a device for multi-stage heat exchange and to a method for producing one such device, whereby at least three free-flowing media (fluids) are used in three flow devices subdivided into at least two heat-exchanging or flow modules. Said modules respectively consist of at least two flow elements that are arranged in such a way that different fluids alternately flow through the same. For essentially liquid fluids, the fluids are distributed to the flow elements by means of fluid collecting devices or fluid distributing devices connected in a gas-tight and liquid-tight manner. The main flow directions of all fluids in the flow elements are in essentially parallel planes. At least two flow modules are directly mounted in series and/or by means of fluid distributing devices in a flow-connected manner at least in relation to one flow device.
Patent MX-PA06000194-A (MX)
Title: Fluid bed granulation process and apparatus.
Inventor: BEDETTI GIANFRANCO
IPC: B01J2/16
Filed: 2004-05-19
Abstract: Fluid bed granulation process of an appropriate substance, comprising the cooling in a second fluid bed of the granules obtained. The same flow of fluidification air is used to form and support both fluid beds.
Patent MX-PA06005598-A (MX)
Title: Inhibitors of the mutant form of kit.
Inventor: FABBRO DORIANO
IPC: A61P35/02
Filed: 2004-11-17
Abstract: The present invention relates to the treatment of KIT dependent diseases that are characterized by a mutant form of KIT whereby the mutant KIT is identified and an appropriate inhibitor of the mutant KIT selected form midostaurin, vatalanib and compound A is administered.
Patent MX-PA06006386-A (MX)
Title: Rubber material and method for production thereof.
Inventor: GEILENKIRCHEN ROBERT
IPC: B60S1/38
Filed: 2004-11-17
Abstract: A rubber material, in particular, for wiper blades on windscreen wipers, or for motor vehicle tyres, is disclosed, containing at least one type of rubber, at least one filler and processing adjuncts. The rubber material comprises a first and a second fraction of at least one of the types of rubber contained therein which differ in viscosity in the unvulcanised state thereof.
Patent MX-PA06007420-A (MX)
Title: Method and apparatus for a molded tube and peristaltic pump.
Inventor: SCHROEDER ALFRED A
IPC: F04B43/09
Filed: 2005-01-13
Abstract: A peristaltic pump (10) and tube (18) system are provided. The peristaltic pump (10) operates to squeeze the tube (18) and push liquid in the tube (18) in the desired direction. The tube (18) is molded, and thus allows for predictable and consistent flow rates.
Patent MX-PA06008117-A (MX)
Title: Screening deck.
Inventor: MALMBERG MATS
IPC: B07B1/00
Filed: 2005-01-19
Abstract: A screening deck (100) for screening of material, such as crushed stone, gravel or the like, the screening deck (100) comprising screening elements (110a, 110b), and where at least one side of each screening element (110a, 110b) is not parallel with a longitudinal direction (A) of the screening deck (100), and that the screening deck (100) includes at least two different types of said screening elements (110a, 110b), and that different screening elements (110a, 110b) are arranged at different heights in the screening deck (100) for creating narrowing passages or winding paths for the material on the screening deck (100).
Patent MX-PA06008177-A (MX)
Title: Elevator cabin door.
Inventor: HOERLER MARCO
IPC: B66B13/30
Filed: 2005-01-21
Abstract: The present invention concerns an elevator cabin door folding around a vertical axis during its closing movement and is based on the concept of making the door subject to a continuous tension exercised by a energy accumulator (preferably a spring) in order to keep the door opened, while, on the other door side, a traction action in opposite direction is exercised by means of two traction means (6, 7) that always pull the door and that wind around a second motorised vertical axis (8). The cabin door can then be mechanically coupled with a landing entrance door (11) so that the cabin door opening provokes the landing entrance door opening by means of dragging. The necessary torque on the different vertical axes of the construction are preferably exercised by cylindrical or helicoidal coil spring acting directly on the axes. The invention advantage mainly consists in the construction simplicity coupled with the reduced overall dimension and with the possibility of forming pre-assembled cabin doors and landing entrance doors and thus ready to be installed on the spot.
Patent MX-PA06010543-A (MX)
Title: Carboline derivatives useful in the inhibition of angiogenesis.
Inventor: QI HONGYAN
IPC: A61K31/4745
Filed: 2005-03-15
Abstract: In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the inhibition of angiogenesis, and/or in the treatment of cancer, diabetic retinopathy or exudative macular degeneration are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the inhibition of angiogenesis, and/or the treatment of cancer, diabetic retinopathy or exudative macular degeneration using the compounds of the invention.
Patent MX-PA06010674-A (MX)
Title: Delivery of functional ingredients.
Inventor: WANG JUNKUAN
IPC: A23L19/00
Filed: 2005-03-14
Abstract: The present invention relates to a primary composition comprising all essential nutrients of a fruit or a plant material, which has an increased stability, bio-availability and miscibility; and the process of forming the same. It also relates to an oral composition that contains the primary composition in a foodstuff, in a food supplement, in a cosmetic preparation or in a pharmaceutical preparation.
Patent MX-PA06014180-A (MX)
Title: Qam signal analysis in a network.
Inventor: TERREAULT GERARD
IPC: G01R31/00
Filed: 2005-06-14
Abstract: A system and method for maintaining an uninterrupted data flow in a communications network includes a transmitter (10), which transmits the data flow from a data source and a receiver (15), which receives the data flow. A channel (14) interconnects the transmitter (10) and the receiver (15); and communicates the dataflow between the transmitter (10) and the receiver (15). A switch (48) is located in the channel (14) between the transmitter (10) and the receiver (15). The switch (48) is openable for a period of time, which is sufficient to permit analysis of signal impairment in the channel (14) without interrupting the data flow.
Patent MX-PA06014724-A (MX)
Title: Pigmentation of ionomers.
Inventor: TYLER MARK A
IPC: B32B5/00
Filed: 2005-06-17
Abstract: Pigment pre-dispersions for use with ionomers, methods for making pigment pre-dispersions for use with ionomers, pigmented , ionomers, and multilayer films containing pigmented ionomers are disclosed. The pigment pre-dispersions generate ormaintain a minimal pigment particle size in order to optimize the dispersability of the pigment in an ionomer upon a single pass through processing equipment.The carrier of the pigment pre idispersion is chosen based on compatibility parameters, such as refractive index and viscosity, to be compatible with theionomer. Carriers can include acid copolymers, acid terpolymers, ionomers, polyethylenes, ethylene vinyl acetate, and ethylene methacrylate. The pigment edionomers created from these pigment pre-dispersions have well dispersed pigment with a particle size of less than or equal to about 25 micrometers. Films or sheet scan be created from the pigmented ionomers and the pigmented ionomers can be used in mulitlayer films.
Patent MY-100304-A (MY)
Title: Method for reducing the molecular weight of rubber latex.
Inventor: PETER GUSTAVE MENTE
IPC: C08C19/08
Filed: 1986-11-28
Abstract: A METHOD FOR REDUCING THE MOLECULAR WEIGHT OF RUBBER IN LATEX FORM OR IN WET COAGULUM FORM COMPRISES TREATING THE LATEX WITH AN OXIDIZING AGENT AND A REDUCING AGENT. THE OXIDIZING AGENT IS AIR, OXYGEN OR A PEROXIDE AND THE REDUCING AGENT IS A METAL NITRITE AND/OR A METAL CHLORITE.@@THE METHOD IS PARTICULARLY SUITED FOR USE WITH NATURAL RUBBER LATEX, INCLUDING EPOXIDIZED NATURAL RUBBER LATEX. DEPENDING UPON THE DEGREE OF REDUCTION OF THE MOLECULAR WEIGHT, THE METHOD MAY BE USED I) IN THE PREPARATION OF LIQUID RUBBER, II) IN THE PREPARATION OF IMPROVED LATEX ADHESIVES AND III) IN THE CONTROL OFTHE VISCOSITY OF RUBBER DURING NORMAL PRODUCTION.
Patent MY-102296-A (MY)
Title: Antimicrobial suspensions and antimicrobial hair treatment compositions
Inventor: SUSUMU TAKAYA
IPC: A61K8/04
Filed: 1987-03-24
Abstract: A PLYVALENT METAL SALT OF-2 MERCAPTOPYRIDINE-N-OXIDE (MEPT COMPOUND) IS DISPERSED IN WATER BY AID OF A SPECIFIC DISPERSANT SELECTED FROM THE GROUP CONSISTING OF (A), (B) AND (C): (A) A POLYGLYCOL/POLYAMINE CONDENSATION POLYMER, POLYGLYCOL/POLYAMINE/ALKYLAMINE CONDENSATION POLYMER OR ALKYLENEAMINE CONDENSATION POLYMER; (B) AT LEAST ONE WATER-SOLUBE POLYMER COMPOUND SELECTED FROM THE GROUP CONSISTING OF HYDROXYALCELLUOSES AND PARTY QUATERNARIZED PRODUCTS THEREOF, AND AT LEAST ONE NON-IONIC SURFACTANT; (C) AT LEAST ONE CATIONIC POLYMER COMPOUND AND AT LEAST ONE INORGANIC SALT.THE RESULTING SUSPENSION HAS IMPROVED STABILITY AND IS APPLICABLE TO SHAMPOOES, HAIR RINSES AND THE LIKE.
Patent MY-101824-A (MY)
Title: Data storage apparatus for portable label printer.
Inventor: ISAO WATANABE
IPC: G06K1/00
Filed: 1987-08-25
Abstract: A DATA STORAGE APPARATUS FOR USE WITH A PORTABLE LABEL PRINTER IS COMPRISED OF A MEANS FOR STORING THE DATA TO BE PRINTED ON THE LABELS, A MULTI-KEY MEANS OF SELECTIVELY ACCESSING AND RETRIEVING THE STORED DATA FOR OUTPUT TO THE PORTABLE LABEL PRINTER, AND A BATTERY-TYPE POWER SUPPLY. THE APPARATUS IS LIGHT AND COMPACT AND CAN BE CONVENIENTLY EMPLOYED WHEREVER REQUIRED. (FIG. 1)
Patent MY-102409-A (MY)
Title: Septic anaerobil filter tank
Inventor: DR KSEMSON SUWARNARAT
IPC: C02F3/30
Filed: 1988-01-14
Abstract: THERE IS DISCLOSED A SEPTIC ANACROBIC FILTER TANK COMPRISING AN OUTER EASING (4) WITH A FILTER CHAMBER (6) FILLLED WITH BIOMEDIA (24). 3 PIPES (18, 20, 22) ARE AFFIXED AT THE BOTTOM OF THE FILTER CHAMBER (6). A COVER-CUM-RECEIVING TROUGH (26) IS PLACED AT THE TOP OF THE FILTER CHAMBER TO HOLD THE BIOMEDIA IN PLACE. A SCUM BOX (28) IS PLACED AT THE UPPER PART OF THE TANK TO RECEIVE SEWAGE FROM AN INLET PIPE (12). AN OUTLET PIPE (10) IS PLACED OPPOSING THE INLET PIPE(12) AT THE TOP OF THE TANK. THE SEPARATION CHAMBER (32) IS AT THE BOTTOM OF THE TANK. THERE ARE TWO AIR VENTILATION PIPES (14, 16), A MANHOLE COVER (8) AND A SLUDGE DRAIN MANHOLE COVER (30) AT THE TOP OF THE TANK.(FIG 1)